Site Members can sign up for company wide alerts
Lawsuit Overview
November 01, 2023 - An investor in shares of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) filed a lawsuit in the U.S. District Court for the Southern District of New York over alleged violations of Federal Securities Laws by Brainstorm Cell Therapeutics Inc. in connection with certain allegedly false and misleading statements made between August 15, 2022 and September 27, 2023. Ne...
You must register (for free) or login to view the entire case.